Cargando…
PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance
PURPOSE: Programmed death-ligand 1 (PD-L1) has been widely used as a prognostic biomarker and an immunotherapeutic target in numerous cancers, but information on the clinical significance of its expression in endometrial serous carcinoma (ESC) is largely lacking. Here, we evaluate the predictive val...
Autores principales: | Zhang, Tao, Liu, Qin, Zhu, Yingfan, Zhang, Songfa, Peng, Qiaohua, Strickland, Amanda Louise, Zheng, Wenxin, Zhou, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684396/ https://www.ncbi.nlm.nih.gov/pubmed/34934360 http://dx.doi.org/10.2147/CMAR.S337271 |
Ejemplares similares
-
The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma
por: Zhou, Feng, et al.
Publicado: (2022) -
Metastatic serous endometrial carcinoma to the ureter
por: Sahl, Jessa W., et al.
Publicado: (2021) -
Lymphocyte and macrophage infiltration in omental metastases indicates poor prognosis in advance stage epithelial ovarian cancer
por: Zhang, Tao, et al.
Publicado: (2021) -
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
por: Strickland, Kyle C., et al.
Publicado: (2016) -
PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas
por: Zhang, Shuang, et al.
Publicado: (2020)